Skip to Content

P-5908

Main Content

JCO Oncology Practice | 2024

Cost-effectiveness of reduced-intensity allogeneic hematopoietic cell transplantation for older patients with high-risk myelodysplastic syndrome: Analysis of BMT CTN 1102.

Saber W, Bansal A, Li L, Scott BL, Sangaralingham LR, Thao V, Roth JA, Wright W, Steuten LMG, Pidala JA, Mishra A, Maziarz RT, Westervelt P, McGuirk JP, Cutler C, Nakamura R, Ramsey SD

PubMed
PMID: 38261970

Abstract
Related Articles

CIBMTR Study #: 1102